All Relations between Depression and serotonin

Publication Sentence Publish Date Extraction Date Species
O Chernoloz, M El Mansari, P Blie. Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 34. issue 3. 2009-03-30. PMID:18688211. in conclusion, the therapeutic action of ppx in depression might be attributed to increased da and 5-ht neurotransmission. 2009-03-30 2023-08-12 rat
Bernhard T Baune, Christa Hohoff, Lena S Mortensen, Jürgen Deckert, Volker Arolt, Katharina Domschk. Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect? Depression and anxiety. vol 25. issue 11. 2009-03-24. PMID:18050262. serotonin transporter polymorphism (5-httlpr) association with melancholic depression: a female specific effect? 2009-03-24 2023-08-12 Not clear
Bernhard T Baune, Christa Hohoff, Lena S Mortensen, Jürgen Deckert, Volker Arolt, Katharina Domschk. Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect? Depression and anxiety. vol 25. issue 11. 2009-03-24. PMID:18050262. earlier studies yielded inconsistent results on the association between variation in the serotonin transporter (5-htt) gene and depression, with evidence for a differential effect of the 5-httlpr on melancholic versus atypical depression. 2009-03-24 2023-08-12 Not clear
Bernhard T Baune, Christa Hohoff, Lena S Mortensen, Jürgen Deckert, Volker Arolt, Katharina Domschk. Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect? Depression and anxiety. vol 25. issue 11. 2009-03-24. PMID:18050262. the present results provide further support for an association of genetic variation increasing serotonin transporter activity with the melancholic subtype of depression as well as evidence for a potential female-specific mechanism underlying this effect. 2009-03-24 2023-08-12 Not clear
Meera Sheffrin, Henry C Driscoll, Eric J Lenze, Benoit H Mulsant, Bruce G Pollock, Mark D Miller, Meryl A Butters, Mary Amanda Dew, Charles F Reynold. Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission. The Journal of clinical psychiatry. vol 70. issue 2. 2009-03-23. PMID:19210951. to determine the feasibility and safety of aripiprazole augmentation for incomplete response to sequential selective serotonin reuptake inhibitor (ssri) and serotonin-norepinephrine reuptake inhibitor (snri) pharmacotherapy in late-life depression. 2009-03-23 2023-08-12 Not clear
Philip Gerretsen, Bruce G Polloc. Pharmacogenetics and the serotonin transporter in late-life depression. Expert opinion on drug metabolism & toxicology. vol 4. issue 12. 2009-03-19. PMID:19040324. pharmacogenetics and the serotonin transporter in late-life depression. 2009-03-19 2023-08-12 Not clear
Philip Gerretsen, Bruce G Polloc. Pharmacogenetics and the serotonin transporter in late-life depression. Expert opinion on drug metabolism & toxicology. vol 4. issue 12. 2009-03-19. PMID:19040324. the serotonin transporter-linked polymorphic region (5-httlpr) is the most widely studied polymorphism of the 5-htt gene, slc6a4, and is suspected of conferring vulnerability to elderly depression and resistance to treatment. 2009-03-19 2023-08-12 Not clear
Patrícia Pereira, Janaína Gianesini, Cibele da Silva Barbosa, Graziela Freitas Cassol, Rafael Gomes Von Borowski, Vivian Francília Silva Kahl, Shandale Emanuele Cappelari, Jaqueline Nascimento Picad. Neurobehavioral and genotoxic parameters of duloxetine in mice using the inhibitory avoidance task and comet assay as experimental models. Pharmacological research. vol 59. issue 1. 2009-03-17. PMID:18973814. duloxetine is a potent inhibitor of serotonin and noradrenaline reuptake, with weak effects on dopamine reuptake, used in the treatment of major depression. 2009-03-17 2023-08-12 mouse
Shinji Kusakawa, Junji Yamauchi, Yuki Miyamoto, Atsushi Sanbe, Akito Tanou. Estimation of embryotoxic effect of fluoxetine using embryonic stem cell differentiation system. Life sciences. vol 83. issue 25-26. 2009-03-17. PMID:18996131. fluoxetine is an antidepressant drug of the selective serotonin reuptake inhibitor (ssri) class, which is commonly prescribed to treat a wide spectrum of mood disorders including depression during pregnancy and lactation. 2009-03-17 2023-08-12 mouse
Sefi Kronenberg, Amos Frisch, Beni Rotberg, Miri Carmel, Alan Apter, Abraham Weizma. Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety. Pharmacogenomics. vol 9. issue 11. 2009-03-06. PMID:19018726. pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety. 2009-03-06 2023-08-12 Not clear
Sefi Kronenberg, Amos Frisch, Beni Rotberg, Miri Carmel, Alan Apter, Abraham Weizma. Pharmacogenetics of selective serotonin reuptake inhibitors in pediatric depression and anxiety. Pharmacogenomics. vol 9. issue 11. 2009-03-06. PMID:19018726. selective serotonin reuptake inhibitors (ssris) are now an accepted and widely used first-line treatment for pediatric depression and anxiety. 2009-03-06 2023-08-12 Not clear
Debra Rose Wilson, Lita Waris. Cytokines and their role in depression. Perspectives in psychiatric care. vol 44. issue 4. 2009-03-05. PMID:18826467. this study aims to review the cytokines that mediate the inflammatory process, the interleukins and the interferons, and the interaction of cytokines with serotonin as causative factors in the role of depression. 2009-03-05 2023-08-12 Not clear
Marian J Bakermans-Kranenburg, Marinus H van Ijzendoor. Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting. Social cognitive and affective neuroscience. vol 3. issue 2. 2009-03-04. PMID:19015103. we examined the role of serotonin transporter (5-htt) and oxytocin receptor (oxtr) genes in explaining differences in sensitive parenting in a community sample of 159 caucasian, middle-class mothers with their 2-year-old toddlers at risk for externalizing behavior problems, taking into account maternal educational level, maternal depression and the quality of the marital relationship. 2009-03-04 2023-08-12 human
Lesley M Arnold, Rakesh Jain, William M Glaze. Pain and the brain. The Journal of clinical psychiatry. vol 69. issue 9. 2009-03-03. PMID:19026270. for example, depression is associated with abnormalities in serotonin and norepinephrine, neurotransmitters that also modulate the endogenous analgesic system. 2009-03-03 2023-08-12 Not clear
Eric J Peters, Susan L Slager, Greg D Jenkins, Megan S Reinalda, Holly A Garriock, Stanley I Shyn, Jeffrey B Kraft, Patrick J McGrath, Steven P Hamilto. Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response. Pharmacogenetics and genomics. vol 19. issue 1. 2009-03-03. PMID:19077664. here, we attempt to expand upon and replicate these results by (i) resequencing the exonic and putatively regulatory regions of five serotonin-related candidate genes (htr1a, htr2a, tph1, tph2, and maoa) in our fluoxetine-treated sample to uncover novel variants; (ii) selecting tagging single nucleotide polymorphisms (snps) for these genes from the resequencing data; and (iii) evaluating these tagging snps for association with response to the selective serotonin reuptake inhibitor citalopram in an independent sample of participants who are enrolled in the sequenced treatment alternatives to relieve depression (star*d) clinical study (n=1953). 2009-03-03 2023-08-12 human
Alain M Gardie. Mutant mouse models and antidepressant drug research: focus on serotonin and brain-derived neurotrophic factor. Behavioural pharmacology. vol 20. issue 1. 2009-03-03. PMID:19179848. constitutive ko, tissue specific, or inducible ko mice targeting both 5-ht and brain-derived neurotrophic factor systems may potentially make an important contribution to knowledge of the pathophysiology and treatment of depression. 2009-03-03 2023-08-12 mouse
Robert Gibbons, J John Man. Proper studies of selective serotonin reuptake inhibitors are needed for youth with depression. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. vol 180. issue 3. 2009-03-03. PMID:19188617. proper studies of selective serotonin reuptake inhibitors are needed for youth with depression. 2009-03-03 2023-08-12 Not clear
Corrado Barbui, Eleonora Esposito, Andrea Ciprian. Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. vol 180. issue 3. 2009-03-03. PMID:19188627. it is unclear whether the use of selective serotonin reuptake inhibitors (ssris) and other antidepressant drugs reduce the risk of suicide in people with depression. 2009-03-03 2023-08-12 Not clear
Dimitris Tousoulis, Charalambos Antoniades, Apostolos Drolias, Elli Stefanadi, Kyriakoyla Marinou, Carmen Vasiliadou, Costas Tsioufis, Kostas Toutouzas, George Latsios, Christodoulos Stefanadi. Selective serotonin reuptake inhibitors modify the effect of beta-blockers on long-term survival of patients with end-stage heart failure and major depression. Journal of cardiac failure. vol 14. issue 6. 2009-02-24. PMID:18672192. selective serotonin reuptake inhibitors modify the effect of beta-blockers on long-term survival of patients with end-stage heart failure and major depression. 2009-02-24 2023-08-12 Not clear
Smita Thakker-Varia, Janet Alde. Neuropeptides in depression: role of VGF. Behavioural brain research. vol 197. issue 2. 2009-02-23. PMID:18983874. one class of genes regulated by both bdnf and serotonin (5-ht) are neuropeptides including vgf (non-acryonimic) which has a novel role in depression. 2009-02-23 2023-08-12 Not clear